Q3 2017

Latest Quarterly Results
Ended March 31, 2017

$714,889

Research and development YTD

$1,449,080

Net cash used in operations YTD

FAQ

  • What is Propanc Biopharma, Inc.'s stock symbol?
  • Our stock is traded on the OTCQB under the symbol PPCB.

  • When was Propanc Biopharma, Inc. incorporated?
  • 2007

  • When did Propanc Biopharma, Inc. become a public company?
  • Propanc officially became a public company on December 16th, 2011.

  • Where is Propanc Biopharma, Inc. located?
  • 302/6 Butler Street
    Camberwell, VIC 3124
    Australia

  • When is Propanc Biopharma, Inc.'s fiscal year end?
  • June 30th

  • Who is Propanc Biopharma, Inc.'s transfer agent?
  • Corporate Stock Transfer Inc.
    3200 Cherry Creek South Drive
    Suite 430
    Denver, CO 80209
    T: 303-282-4800
    dbell@corporatestock.com
    www.corporatestock.com

  • Who is Propanc Biopharma, Inc.'s independent auditor?
  • Salberg & Co
    2295 N.W. Corporate Blvd.
    Suite 240
    Boca Raton, FL 33431
    T: 561-995-8270 ext. 310
    scottsalberg@salbergco.com
    www.salbergco.com

  • Who is Propanc Biopharma, Inc.'s outside legal counsel?
  • Harter Secrest & Emery LLP
    1600 Bausch & Lomb Place
    Rochester, NY 14604
    T: 585-232-6500

  • Whom can I contact for general information about Propanc Biopharma, Inc.?
  • KCSA Strategic Communications
    Philip Carlson
    880 Third Ave
    6th Floor
    New York, NY 10022
    T: 212-896-1233
    pcarlson@kcsa.com

Sign up for email alerts

Be the first to receive breaking news

Sign up today